Severe obesity is associated with novel single nucleotide polymorphisms of the ESR1 and PPARγ locus in Han Chinese

American Journal of Clinical Nutrition

Volumn 90, Issue 2, 2009, Pages 255-262

  Chen, Hsin Hung ^a,b   Lee, Wei Jei ^c,d   Fann, Cathy S J ^b   Bouchard, Claude ^e   Pan, Wen Harn ^b,f  

^a CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c MIN SHENG GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^f NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ESR1 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; ESTROGEN RECEPTOR 1 GENE; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; CASE CONTROL STUDY; CHINA; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; MORBID OBESITY; RISK; RISK ASSESSMENT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; RISK ASSESSMENT; YOUNG ADULT;

EID: 67949111113     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.25914     Document Type: Article

References (41)

1. Bray GA. Overweight is risking fate: definition, classification, prevalence, and risks. Ann N Y Acad Sci 1987;499:14-28.
2. Martinez JA. Body-weight regulation: causes of obesity. Proc Nutr Soc 2000;59:337-345
3. Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006;14:529-644.
4. Picard F, Auwerx J. PPAR(gamma) and glucose homeostasis. Annu Rev Nutr 2002;22:167-197
5. Carmen GY, Victor SM. Signalling mechanisms regulating lipolysis. Cell Signal 2006;18:401-408
6. Rosen ED, Sarraf P, Troy AE, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999;4:611-617 (Pubitemid 29531140)
7. Mattevi VS, Coimbra CE Jr, Santos RV, Salzano FM, Hutz MH. Association of the low-density lipoprotein receptor gene with obesity in Native American populations. Hum Genet 2000;106:546-552 (Pubitemid 30406681)
8. Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 2002;282:E207-14.
9. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005;6:221-234
10. van RossumEF, Roks PH, de Jong FH, et al. Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin Endocrinol (Oxf) 2004;61:573-581
11. Rosmond R, Chagnon YC, Holm G, et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res 2000;8:211-218
12. Cabrera-Vera TM, Vanhauwe J, Thomas TO, et al. Insights into G protein structure, function, and regulation. Endocr Rev 2003;24:765-781 (Pubitemid 38067698)
13. Roussel R, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2003;59:237-241 (Pubitemid 36918661)
14. Sluse FE, Jarmuszkiewicz W, Navet R, Douette P, Mathy G, Sluse-Goffart CM. Mitochondrial UCPs: new insights into regulation and impact. Biochim Biophys Acta 2006;1757:480-485
15. Berthier MT, Paradis AM, Tchernof A, et al. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 2003;48:14-19 (Pubitemid 36205641)
16. Corbalan MS, Marti A, Forga L, Patino A, Martinez-Gonzalez MA, Martinez JA. Influence of two polymorphisms of the tumoral necrosis factor-alpha gene on the obesity phenotype. Diabetes Nutr Metab 2004;17:17-22. (Pubitemid 38578513)
17. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001;280:E827-47.
18. Pyrzak B, Wisniewska A, Rymkiewicz-Kluczynska B. [Tumor necrosis factor alpha (TNF-alpha) gene G-308A polymorphism relationship to insulin resistance and lipid abnormalities in children with obesity.] Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2006;12:171-174 (in Polish). (Pubitemid 44520952)
19. Nicaud V, Raoux S, Poirier O, Cambien F, O'Reilly DS, Tiret L. The TNF alpha/G-308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II. Atherosclerosis 2002;161:317-325 (Pubitemid 34219184)
20. Fontaine-Bisson B, Wolever TM, Chiasson JL, et al. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus. Metabolism 2007;56:649-655 (Pubitemid 46574727)
21. Perusse L, Rankinen T, Zuberi A, et al. The human obesity gene map: the 2004 update. Obes Res 2005;13:381-490.
22. Rong R, Tao YX, Cheung BM, Xu A, Cheung GC, Lam KS. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population. Clin Endocrinol (Oxf) 2006;65:198-205. (Pubitemid 44079683)
23. Peeters A, Beckers S, Verrijken A, et al. Variants in the FTO gene are associated with common obesity in the Belgian population. Mol Genet Metab 2008;93:481-484
24. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316:889-894
25. Lin YC, Yen LL, Chen SY, et al. Prevalence of overweight and obesity and its associated factors: findings from National Nutrition and Health Survey in Taiwan, 1993-1996. Prev Med 2003;37:233-241
26. Pan WH, Fann CS, Wu JY, et al. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered 2006;61:27-30.
27. Huang Q, Wang TH, Lu WS, et al. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou. Chin Med J (Engl) 2006;119:1794-1801 (Pubitemid 44768609)
28. Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H. Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord 2003;27:1020-1027 (Pubitemid 37059606)
29. Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol Behav 2006;88:227-233 (Pubitemid 43913893)
30. Rosen ED, Spiegelman BM. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001;276:37731-37734 (Pubitemid 37384014)
31. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia 1999;42:1033-1049
32. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994;8:1224-1234 (Pubitemid 2102252)
33. Fajas L, Fruchart JC, Auwerx J. PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett 1998;438:55-60. (Pubitemid 28517834)
34. Sabatino L, Casamassimi A, Peluso G, et al. A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing. J Biol Chem 2005;280:26517-26525
35. Fajas L, Auboeuf D, Raspe E, et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 1997;272:18779-18789
36. Sundvold H, Lien S. Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1. Biochem Biophys Res Commun 2001;287:383-390 (Pubitemid 32917609)
37. Santos JL, Boutin P, Verdich C, et al. Genotype-by-nutrient interactions assessed in European obese women. A case-only study. Eur J Nutr 2006;45:454-462 (Pubitemid 46020596)
38. Doney A, Fischer B, Frew D, et al. Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 2002;3:21.
39. Nagy TR, Blaylock ML, Garvey WT. Role of UCP2 and UCP3 in nutrition and obesity. Nutrition 2004;20:139-144
40. Ukkola O, Tremblay A, Sun G, Chagnon YC, Bouchard C. Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding. Eur J Clin Nutr 2001;55:1008-1015 (Pubitemid 33040099)
41. Bonofiglio D, Gabriele S, Aquila S, et al. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. Clin Cancer Res 2005;11:6139-6147 (Pubitemid 41262940)